BMJ  2003;326:1145 (24 May), doi:10.1136/bmj.326.7399.1145-a

Letter

Beyond single and dual diagnosis in general practice

Patients who do not comply with polypharmacy may be safer

The first 100% of the full text of this article appears below.

EDITOR—I concur with Wright et al's unease about polypharmacy.1 Consultants with narrower interests simply bolt on their particular care package if the patient is referred in their direction.

Dare I suggest that general practitioners are specialists in "multiple morbidity," which may often include persistent unexplained physical symptoms and some degree of somatisation. Could it be incumbent on us as general practitioners to edit the Leviathan of the modern prescription without recourse to our bewildered hospital colleagues?

Are we ready to admit that the dangers of polypharmacy usually outweigh the small absolute benefits of each drug? Half our patients will not manage to comply in any case. Perhaps they are the safer.

David J Young, general practitioner principal

Derby DE2 7RJ David.J.Young@btinternet.com


Competing interests: None declared.

  1. Wright N, Smeeth L, Heath I. Moving beyond single and dual diagnosis in general practice. BMJ 2003;326: 512-4. (8 March.)[Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Moving beyond single and dual diagnosis in general practice
Nat Wright, Liam Smeeth, and Iona Heath
BMJ 2003 326: 512-514. [Extract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ